Carol Lynch
Corporate Officer/Principal presso Sandoz, Inc.
Provenienza dei contatti di primo grado di Carol Lynch
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Carol Lynch tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
THERATECHNOLOGIES INC. | Pharmaceuticals: Major | Director/Board Member | |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President | |
TETRALOGIC PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Investor Relations Contact | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
GFK AG | Miscellaneous Commercial Services | Director/Board Member | |
STADA ARZNEIMITTEL | Pharmaceuticals: Other | Chief Executive Officer | |
Drexel University | College/University | Graduate Degree | |
York University | College/University | Undergraduate Degree | |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Concordia University | College/University | Masters Business Admin | |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Investor Relations Contact | |
Villanova University | College/University | Undergraduate Degree | |
University of Münster | College/University | Graduate Degree | |
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Galderma Laboratories LP develops and markets dermatology and prescription products. It also offers treatments for skin conditions such as acne, rosacea, atopic dermatitis, soriasis, melasma and sunspots. Galderma Laboratories was founded in 1961 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director of Finance/CFO | |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Pharmaceuticals: Major | Sales & Marketing | |
Novartis Healthcare Philippines, Inc. | Corporate Officer/Principal | ||
MAYNE PHARMA GROUP LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bristol-Myers Squibb Canada Co.
Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Fougera Pharmaceuticals, Inc.
Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fougera Pharmaceuticals, Inc. develops and manufactures specialty pharmaceuticals in dermatology. It operates through two core divisions: PharmaDerm and Fougera. The PharmaDerm division offers in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The company was founded in 1849 and is headquartered in Melville, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
Temple University School of Medicine | College/University | Doctorate Degree | |
Galderma Holding SA
Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Macrophage Therapeutics, Inc.
Macrophage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Navidea Biopharmaceuticals, Inc., Macrophage Therapeutics, Inc. develops immune-oncology and anti-inflammatory therapeutics. The CEO of the American company is Mike M. Goldberg. | Miscellaneous Commercial Services | Chief Operating Officer | |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Pharma (Sweeden) | Sales & Marketing | ||
Nidda German Topco GmbH
Nidda German Topco GmbH MiscellaneousMiscellaneous Part of Nidda Topco SARL, Nidda German Topco GmbH is an investment holding company. The company is based in Bad Vilbel, Germany. The CEOs of the company are Andreas Grundhöfer and Peter Goldschmidt. | Miscellaneous | Chief Executive Officer | |
SCHOTT PHARMA AG & CO. KGAA | Medical Specialties | Chairman | |
CASI PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
Stati Uniti | 14 |
Germania | 8 |
Canada | 6 |
Regno Unito | 3 |
Filippine | 2 |
Settori
Health Technology | 21 |
Consumer Services | 7 |
Commercial Services | 4 |
Miscellaneous | 2 |
Posizioni
Corporate Officer/Principal | 17 |
Director/Board Member | 4 |
Undergraduate Degree | 3 |
Chief Executive Officer | 3 |
Investor Relations Contact | 2 |
Contatti più connessi
Insiders | |
---|---|
James E. Goldschmidt | 12 |
Peter Goldschmidt | 12 |
Sheila Frame | 8 |
Brant Schofield | 4 |
John Pakulski | 2 |
- Borsa valori
- Insiders
- Carol Lynch
- Connessioni Società